Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TEBENTAFUSP-TEBN: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

53.0%
Female
47.0%
Male

Age Information

The average age of patients reporting adverse events with TEBENTAFUSP-TEBN is 68.3 years.

Geographic Distribution

The majority of adverse event reports for TEBENTAFUSP-TEBN originate from US.

Report Summary & Outcomes

350
Total Reports
350
As Primary/Secondary Suspect
45
Deaths Reported
112
Hospitalizations
14
Life-Threatening

Reporting Timeline

First adverse event report: 20210101. Most recent report: 20250902. View full timeline →

More About TEBENTAFUSP-TEBN

TEBENTAFUSP-TEBN Full Profile Reports by Year Drug Interactions